Embedded Chimeric Peptide Nucleic Acids for Viral-Free Gene Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating induced pluripotent stem (iPS) cells are limited by the use of viral transduction, which leads to permanent genetic alterations and inefficiency, and there is a need for novel compounds that can efficiently modulate gene expression without toxicity for treating β-globin disorders and generating iPS cells.
Innovation Solution
Development of embedded chimeric peptide nucleic acid (ecPNA) molecules that target specific promoter regions of genes like OCT4, SOX2, and γ-globin, conjugated with cell and nuclear entry sequences and transcription activation or repression domains, allowing for efficient gene modulation and iPS cell induction without viral vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If viral transduction is used to generate iPS cells, then gene expression can be induced, but permanent genetic alterations occur and the process becomes inefficient
Solution Approach 1:
The invention extracts and eliminates the viral vector component from the iPS cell generation process, replacing it with non-viral PNA-based gene modulation. This removes the source of permanent genetic alterations while maintaining the ability to induce pluripotency gene expression, thereby resolving the contradiction between efficiency and genetic stability.
Solution Approach 2:
The invention introduces PNA (peptide nucleic acid) molecules as an intermediary mechanism to modulate gene expression. These PNA molecules can bind to specific DNA sequences and influence transcription without integrating into the host genome, thus achieving efficient gene induction while preserving genetic stability and avoiding viral-related risks.
2Reliability
If traditional methods are used to treat β-globin disorders, then gene modulation can be achieved, but toxicity occurs
Solution Approach 1:
The invention changes the chemical and biological parameters of the therapeutic agent by using PNA molecules with specific structural characteristics (peptide backbone, nucleotide sequences). These parameter changes enable selective binding to β-globin promoter regions, achieving therapeutic efficacy through precise gene modulation while minimizing off-target effects and toxicity associated with traditional methods.
3Productivity
If viral vectors are used for gene delivery, then gene expression can be induced, but the process becomes complex and inefficient
Solution Approach 1:
The invention extracts and removes the complex viral vector delivery system, replacing it with simpler PNA-based molecules that can be directly administered. This eliminates the need for viral production, purification, and integration steps, thereby reducing overall process complexity while maintaining or improving gene expression induction efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The ecPNA molecules effectively upregulate or downregulate target gene expression, achieving therapeutically significant increases in γ-globin expression and facilitating the generation of iPS cells with increased efficacy and safety compared to traditional methods.
Implementation Method 1
B represents a peptide nucleic acid (PNA) structure at least 12 nucleotides in length, the sequence of which is capable of hybridizing with a DNA within the nucleus of the cell
Data Source
AI summary
The present invention relates to an ecPNA having the general structure:H2N—X—B—Y—COOHand uses thereof, wherein X is A or C and Y is A or C with the proviso that when X is A, Y is C, and when X is C, Y is A; A represents an oligopeptide structure, the sequence of which comprises a sequence which renders the compound able to enter the nucleus of a cell; B represents a peptide nucleic acid (PNA) structure at least 12 nucleotides in length, the sequence of which is capable of hybridizing with a DNA within the nucleus of the cell, which DNA is within a promoter region of a gene; C represents an oligopeptide structure; and each — represents a chemical linkage between the structures at each side thereof, which may be the same as or different from each other such linkage.